In vitro evaluation of antimicrobial features of vasopressors  by Bostan, Habib et al.
RS
I
H
a
b
c
d
e
R
A
H
0
hev Bras Anestesiol. 2014;64(2):84--88
REVISTA
BRASILEIRA  DE
ANESTESIOLOGIA Ofﬁcial  Publication  of the  Brazilian  Society  of  Anesthesiologywww.sba.com.br
CIENTIFIC ARTICLE
n  vitro  evaluation  of antimicrobial  features  of  vasopressors
abib Bostana, Yakup Tomakb, Sengul Alpay Karaogluc, Basar Erdivanlid, Volkan Hancie,∗
The  Council  of  Forensic  Medicine,  Ministry  of  Justice,  Istanbul,  Turkey
Department  of  Anesthesiology  and  Reanimation,  Medical  Faculty  of  Sakarya  University,  Sakarya,  Turkey
Department  of  Biology,  Faculty  of  Arts  and  Sciences  of  Rize  University,  Rize,  Turkey
Department  of  Anesthesiology  and  Reanimation,  Medical  Faculty  of  Rize  University,  Rize,  Turkey
C¸anakkale  Onsekiz  Mart  University,  Medical  Faculty,  Department  of  Anesthesiology  and  Reanimation,  C¸anakkale,  Turkey
eceived  5  April  2012;  accepted  28  February  2013
vailable  online  11  October  2013
KEYWORDS
Antimicrobial
activities;
Vasopressor  drugs;
Drug contamination
Abstract
Background:  Drugs  administered  as  intravenous  infusion  may  be  contaminated  during  several
stages of  production  or  preparation.  However  studies  focusing  on  antibacterial  effects  of  vaso-
pressor  drugs  are  very  rare.  This  study  investigates  the  in  vitro  antimicrobial  activity  of  the
clinically  used  forms  of  vasopressors.
Materials and  methods:  In  vitro  antimicrobial  activities  of  vasopressor  drugs  of  different  con-
centrations were  investigated  by  using  the  micro  dilution  technique.  Microorganisms  used
in  the  test  were  Escherichia  coli  ATCC  25922,  Yersinia  pseudotuberculosis  ATCC  911,  Pseu-
domonas  aeruginosa  ATCC  10145,  Listeria  monocytogenes  ATCC  43251,  Enterococcus  faecalis
ATCC  29212,  Staphylococcus  aureus  ATCC  25923,  Bacillus  cereus  702  Roma,  Mycobacterium
smegmatis ATCC607,  Candida  albicans  ATCC  60193,  and  Saccharomyces  cerevisiae  RSKK  251.
Antibacterial  assays  were  performed  in  Mueller-Hinton  broth  at  pH  7.3  and  antifungal  assays
were  performed  in  buffered  Yeast  Nitrogen  Base  at  pH  7.0.
Results:  Two  different  dopamine  preparations  showed  antimicrobial  activity.  No  other  study
drug  showed  any  antimicrobial  activity.
Conclusions:  In  our  opinion,  dopamine’s  antibacterial  effects  may  be  advantageous  for  inhib-
iting the  spread  of  bacterial  contamination  during  the  preparation  of  the  infusion  solutions.
However,  it  is  important  that  strict  guidelines  regarding  the  need  for  sterile  equipment  and
deliverables  be  adhered  to  during  all  procedures  performed  in  the  intensive  care  units.
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Introduction
Septic  shock  is  the  primary  cause  of  death  in  critical
care units.  Shock  states  are  primarily  characterized  by
acute circulatory  failure  leading  to  tissue  hypoperfusion,
and potentially  resulting  in  multi-organ  failure.  Observed
hypotension can  be  the  consequence  of  three  major  hemo-
dynamic disorders:  hypovolemia,  vascular  failure,  and  heart
failure.1 When  appropriate  ﬂuid  administration  fails  to
restore adequate  tissue  perfusion  and  arterial  pressure,
vasopressors are  usually  necessary  to  increase  mean  sys-
temic pressure,  cardiac  output,  and  oxygen  delivery.2
In  vitro  studies  focusing  on  catecholamine  molecules
demonstrated proliferation  of  bacteria.3--5 A  portion  of
catecholamines, which  are  used  as  vasopressor,  are  endoge-
nously produced  in  the  body.  However,  catecholamines  used
as vasopressor  drugs  are  synthetically  produced  and  infused
for the  treatment  of  cardiovascular  failure  which  arises  dur-
ing septic  shock.  Dopamine,  dobutamine,  adrenaline  and
noradrenaline are  most  frequently  used  vasopressors  pre-
pared synthetically  with  supplemental  chemicals  having
antioxidant and  antimicrobial  activity.  Sodium  metabisul-
ﬁte, N-acetylcysteine  and  disodium  edetate  are  the  most
frequently used  antioxidant  and  antimicrobials  for  this
purpose in  drugs  commonly  found  in  medical  markets
(Table 1).
Considering several  studies  pointing  catecholamine
molecules’ proliferating  effect  on  bacteria,  we  investigated
commercially prepared  catecholamine  products’  in  vitro
effect on  proliferation  of  several  yeast  and  bacterial  strains
commonly encountered  in  septic  shock.
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Table  1  Study  drugs  and  ingredients.
Catecholamine  Ingredients
Epinephrine  In  1  mL  Ampoule:
-  Epinephrine  0.5  
- Sodium  chloride
- Metabisulﬁte  0.5
- Water  for  inject
Norepinephrine In  4  mL  Ampoule:
-  Norepinephrine  
-  Sodium  metabisu
- Sodium  chloride
- Water  for  inject
Dobutamine In  20  mL  Ampoule
-  Dobutamine  hyd
-  Sodium  metabisu
- Water  for  inject
Dopamine In  5  mL  Ampoule:
-  Dopamine  hydro
- N-acetylcysteine
- Disodium  edetat
- Water  for  inject
Dopamine In  5  mL  Ampoule:
-  Dopamine  hydro
- Sodium  metabisu85
aterials and methods
icroorganisms  used  in  tests  were  obtained  from  the  Reﬁk
aydam Hifzissihha  Institute  (Ankara,  Turkey)  and  were  as
ollows: Escherichia  coli  ATCC  25922,  Yersinia  pseudotu-
erculosis ATCC  911,  Pseudomonas  auroginosa  ATCC  10145,
isteria monocytogenes  ATCC  43251,  Enterococcus  faecalis
TCC 29212,  Staphylococcus  aureus  ATCC  25923,  Bacillus
ereus 709  ROMA,  Mycobacterium  smegmatis  ATCC607,  Can-
ida albicans  ATCC  60193  and  Saccharomyces  cerevisiae
TCC 60193.
Antimicrobial effects  of  the  drugs  were  tested  quan-
itatively in  appropriate  broth  media  using  the  double
ilution method,  and  the  minimum  inhibitory  concentration
MIC) values  in  g/mL  were  determined.6,7 Antibacterial
ssays were  performed  in  Mueller-Hinton  broth  (MH)  (Difco,
etroit, MI)  at  pH  7.3  and  antifungal  assays  were  performed
n buffered  Yeast  Nitrogen  Base  (YNB)  (Difco,  Detroit,  MI)  at
H 7.0.  Each  tested  drug  was  prepared  in  0.1  mL  volumes  of
terile MH  and  YNB  broths  in  concentrations  ranging  from
 g/mL  to  5  mg/mL  for  microdilution.  One  drop  (0.02  mL)
f microorganism’s  suspension  (approximately  106 microor-
anisms per  mL)  was  added  to  the  extract/broth  dilutions.
fter incubation  at  35 ◦C  for  18--72  h,  the  media  were  exam-
ned for  growth.  MIC  is  deﬁned  as  the  lowest  concentration
f drug  showing  no  growth  of  microorganism.  The  dilutions
ithout visible  growth  were  used  to  determine  minimum
actericidal concentration  (MBC)  by  spreading  100  L  of  the
ample across  the  surface  of  dried  MH  and  YNB  agar  plates
ith sterile  glass  rods,  and  then  incubating  at  35 ◦C  for  18  h.
BC of  each  extract  is  deﬁned  as  the  lowest  concentration
mg
 8.5  mg
 mg
ion
bitartarate  8  mg  (equivalent  to  4  mg  norepinephrine  base)
lﬁte  4  mg
 34.35  mg
ion
:
rochloride  280  mg  (equivalent  to  250  mg  dobutamine  base)
lﬁte  4.8  mg
ion
chloride  200  mg
 2  mg
e  2  mg
ion
chloride  200  mg
lﬁte  50  mg
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hat  showed  no  growth  of  microorganism  on  agar  plate.
luconazole, Ampicillin  and  Streptomycin  were  used  as
tandard antifungal  and  antibacterial  drugs,  respectively.
Ingredients  of  study  drugs  widely  used  as  vasopressor  in
edical market  are  presented  in  Table  1.
esults
one  of  the  study  drugs  containing  norepinephrine,
pinephrine  and  dobutamine  showed  any  antimicrobial
ctivity (Table  2).  However  study  drugs  containing  dopamine
howed antimicrobial  activity  (Table  2),  one  of  which
howed no  activity  against  yeast-like  microorganisms.
he solutions  containing  dopamine  (125--1000  g/mL),
-acetylcysteine and  disodium  edetate  (1.25--10  g/mL)
howed bacteriostatic  activity  against  Gram-positive  and
negative microorganisms.  Higher  concentration  solutions
howed bactericidial  activity  against  all  microorganisms
xcept Y.  pseudotuberculosis,  which  is  capsular.  Solutions
f different  concentrations  of  dopamine  (125--500  g/mL),
-acetylcysteine and  disodium  edetate  (1.25--5  g/mL)
esulted in  similar  MIC  and  MBC  values  for  bacterial
trains like  Gram-positive  bacillus  L.  monocytogenes,  Gram-
ositive  coccus  E.  faecalis,  Gram-negative  M.  smegmatis,
hich contain  mycolic  acid  in  their  cell  wall.  However,  these
alues were  markedly  different  for  each  solution.  Solutions
ontaining dopamine  (125--250  g/mL),  N-acetylcysteine
nd disodium  edetate  (1.25--2.5  g/mL)  showed  bacte-
iostatic activity  against  E.  coli,  P.  aeruginosa  and  S.
ureus. Solutions  containing  dopamine  2000  g/mL,  N-
cetylcysteine and  disodium  edetate  20  g/mL  showed  bac-
ericidial activity  against  the  same  microorganisms.  Solu-
ions containing  dopamine  1000  g/mL,  N-acetylcysteine
nd disodium  edetate  10  g/mL  showed  bacteriostatic  and
actericidal activity  against  B.  cereus.
Other  drugs  containing  dopamine  (125--500  g/mL)  and
odium metabisulﬁte  (62.5--125  g/mL)  showed  bacteri-
idial activity  against  all  microorganisms  used  in  the  test.
iscussion
n  this  study,  we  have  found  that  two  different  dopamine
reparations out  of  all  tested  showed  antimicrobial  activity.
Drugs  manufactured  for  intravenous  use  should  be  pre-
ared and  administered  in  sterile  conditions.  Infectious
icroorganisms can  be  introduced  into  the  patient  through
ontaminated containers,  rubber  diaphragm,  needles  and
nfusion sets.  Anesthetic  agents  and  vasopressors  may  be
ontaminated by  microorganisms  during  the  preparation
f an  infusion.  For  this  reason,  the  antimicrobial  effects
f anesthetic  agents  and  vasopressors  have  been  deemed
mportant, and  they  have  been  investigated  in  previous
tudies.8 Notably,  propofol  is  known  to  support  the  growth  of
icroorganisms.8 On  the  other  hand,  previous  studies  have
hown that  morphine  sulphate,  thiopental  sodium,  fentanyl
itrate, dexmedetomidine  and  midazolam  all  have  antimi-
robial effects.8--13 However,  studies  on  the  antimicrobial
ffects of  vasopressors  drugs,  which  are  commonly  used  in
ntensive care  units  (ICU),  are  very  few.
Studies  demonstrating  that  catecholamines  stimulate
rowth of  microorganisms  are  increasing.4,5,14,15 Among
a
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he  causative  factors  are  binding  of  catecholamines  to
ransferrin and  lactoferrin,  enabling  bacteria  to  acquire  nor-
ally inaccessible  ferric-iron14 and  possible  -adrenergic
peciﬁc response  system  of  some  bacteria  to  recognize
atecholamines.15
On  the  other  hand,  additives  having  antioxidant
nd antimicrobial  properties  are  commonly  added  to
ommercial vasopressor  formulas  to  prevent  bacterial
ontamination.16--19 However,  studies  investigating  the
n vitro  antimicrobial  activity  of  clinically  used  commer-
ial forms  of  vasopressors  are  very  few.  Most  commonly
sed additives  in  vasopressors  are  N-acetylcysteine  and  diso-
ium edetate,  which  are  known  as  potent  antioxidants  with
ntimicrobial properties.16--19
This  study  evaluates  the  antimicrobial  properties  of  most
ommonly used  vasopressors  in  the  medical  markets  in  dif-
erent concentrations  by  the  micro-dilution  method.
Vasopressor  drugs  are  administered  as  infusion  through
 preferably  central,  high  caliber  vein  to  ensure  a  steady
tate plasma  concentration.  We  used  the  micro-dilution
ethod to  mimic  different  levels  of  concentrations  since
atecholamines interact  over  a  wide  dose-response  range
nd exhibit  multiple  potencies.
Our  study  revealed  antimicrobial  activity  of  both  of  the
opamine preparates.  No  other  study  drug  was  able  to
nhibit microorganismal  growth  at  any  concentration.  This
nding could  be  explained  by  the  high  sodium  metabisulﬁte
oncentration for  one  of  the  Dopamine  preparate  compared
o norepinephrine,  adrenaline  and  dobutamine  preparates.
Sodium  metabisulﬁte  is  an  oxidizing  agent  active  at  low
H. While  all  the  study  drugs  have  effective  pH  ranges
etween 2.2  and  5.0,  MH  broth  has  a pH  value  of  7.3  ±  0.1
nd buffered  YNB  used  in  our  study  has  a pH  value  of  7.0
t 25 ◦C  (unbuffered  medium  has  a  pH  value  of  5.4  ±  0.2  at
5 ◦C).  Therefore  we  do  not  think  that  sodium  metabisul-
te may  exhibit  any  antimicrobial  activity  at  the  neutral
H. Since  human  blood  has  a  slightly  alkaline  pH  value  of
.35--7.45, and  most  pathogenic  bacteria  prefer  a  narrow
H range  of  6--8,11 we  think  that  this  ﬁnding  is  concordant
ith real-life  applications  of  the  drugs.
The  other  oxidizing  additive  contained  in  tested  drugs
s N-acetylcysteine,  which  was  shown  to  be  a  valuable
ucolytic agent,  capable  to  aid  in  antimicrobial  treatment
f combined  with  antibiotics.  Examples  where  antimicro-
ial activity  of  N-acetylcysteine  is  seen  are  lysis  of  gastric
asal mucosal  layer,  which  enables  Helicobacter  pylori  to
scape from  the  acidic  gastric  secretions20 and  decreasing
ormation of  bioﬁlms  by  reducing  production  of  extracellu-
ar polysaccharide  matrix  and  promoting  the  disruption  of
ature bioﬁlm.21 Both  of  these  activities  are  augmented  by
n acidic  environment,  and  the  slightly  alkaline  pH  levels
stablished in  the  study  broth  environments  may  have  hin-
ered N-acetylcysteine’s  antimicrobial  activity.  However,  as
or metabisulﬁte,  we  conclude  that  a  slightly  alkaline  pH
evel is  more  concordant  with  real-life  applications  of  these
rugs.
It is  important  that  strict  guidelines  regarding  the  need
or sterile  equipment  and  deliverables  be  adhered  to  during
ll procedures  performed  in  the  ICU.  In  some  circumstances,
asopressor drugs  may  be  contaminated  with  microorgan-
sms that  can  then  lead  to  infections.8,9 Thus,  the  antimi-
robial effect  of  vasopressor  drugs  in  these  types  of  settings
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Table  2  Antimicrobial  activity  of  the  compounds  expressed  as  MIC  value  in  100  mL  volume.
Study  drugs Ingredient  Concentration
(g/mL)
MIC  values  (100  mL)
Ec  Yp Pa Li  Ef  Sa  Bc  Ms  Ca  Sc
Norepinephrine
4  mg/4  mL  Ampoule
Norepinephrine  1000  -- -- -- -- -- -- -- -- -- --
Sodium metabisulﬁte 1000  -- -- -- -- -- -- -- -- -- --
Sodium chloride 34.350  -- -- -- -- -- -- -- -- -- --
Adrenalin 0.5  mg/1  mL
Ampoule
Epinephrine  500  -- -- -- -- -- -- -- -- -- --
Sodium metabisulﬁte 500  -- -- -- -- -- -- -- -- -- --
Sodium chloride  8500  --  --  --  --  --  --  --  --  --  --
Dobutamine
250 mg/20  mL  Ampoule
Dobutamine 12.500  -- -- -- --  --  --  --  --  --  --
Sodium  metabisulﬁte 240  -- -- -- --  --  --  --  --  --  --
Dopamin 200  mg/5  mL
Ampoule
Dopamine  40.000  125  125  250  250  125  125  1000  250  --  --
N-acetylcysteine  400  1.25 1.25  2.50  2.50  1.25  1.25  10  2.50  --  --
Disodium  edetate 400  1.25  1.25  2.50  2.50  1.25  1.25  10  2.50  --  --
Dopamine 200  mg/5  mL
Ampoule
Dopamine  40.000  500  500  500  250  250  500  250  250  500  125
Sodium  metabisulﬁte  10.000  125  125  125  62.5  62.5  125  62.5  62.5  125  62.5
Ampicillin 10  2  32  >128  2  2  2  <1
Streptomycin  10  4
Fluconazole  5  <8  <8
Bc, Bacillus cereus 702 Roma; Ca, Candida albicans ATCC 60193; Ec, Escherichia coli ATCC 25922; Ef, Enterococcus faecalis ATCC 29212; Li, Listeria monocytogenes ATCC 43251; Ms,
Mycobacterium smegmatis ATCC607; Pa, Pseudomonas aeruginosa ATCC 10145; Sa, Staphylococcus aureus ATCC 25923; Sc, Saccharomyces cerevisiae RSKK 251; Yp, Yersinia pseudotuber-
culosis ATCC 911.
(--):  no activity.
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28  
s  of  paramount  importance.8,9 In  our  opinion,  dopamine’s
ntibacterial effects  may  be  sufﬁcient  to  inhibit  contamina-
ion during  the  preparation  of  the  infusion  solutions.
We  have  shown  that  dopamine  has  antibacterial  effects
n some  microorganisms  frequently  encountered  in  hospi-
al settings.  We  suggest  that  dopamine  preparations  should
e preferred  in  septic  patients  due  to  their  antimicro-
ial activity  against  several  yeast  and  bacterial  strains
ommonly encountered  in  septic  shock.  However,  trans-
ating such  laboratory  researches  into  recommendations
equires delineation  of  the  interactions  between  cate-
holamines, several  molecules  co-existing  or  co-secreted
ith them,  and  microorganisms  in  their  expected  environ-
ents.
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